Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125401601 | 12540160 | 1 | I | 20160630 | 20160708 | 20160708 | EXP | US-PFIZER INC-2016326569 | PFIZER | 81.00 | YR | F | Y | 58.00000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125401601 | 12540160 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 10 MG, UNK, ON THURSDAY NIGHTS | U | 20702 | 10 | MG | FILM-COATED TABLET | |||||||
| 125401601 | 12540160 | 2 | C | BISOPROLOL | BISOPROLOL | 1 | 10 MG, UNK, ONCE PER WEEK | 0 | 10 | MG | /wk | ||||||||
| 125401601 | 12540160 | 3 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125401601 | 12540160 | 3 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125401601 | 12540160 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125401601 | 12540160 | Diabetes mellitus | |
| 125401601 | 12540160 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125401601 | 12540160 | 2 | 2001 | 0 |